Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 2.430
0.00 (0.00%)
Jun 18, 2026, 10:34 AM HKT
HKG:2185 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -70.05 | -87.94 | -175.89 | -204.24 | -361.45 |
Depreciation & Amortization | 18.05 | 8.05 | 21.27 | 20.86 | 13.23 |
Other Amortization | 0.12 | 0.12 | 0.09 | - | - |
Loss (Gain) From Sale of Assets | - | 1.47 | 30.51 | 0 | - |
Loss (Gain) From Sale of Investments | 18.25 | 32.17 | -0.47 | - | - |
Loss (Gain) on Equity Investments | 1.47 | 0.99 | 1.63 | 1.43 | - |
Stock-Based Compensation | - | - | 47.63 | 140.48 | 318.72 |
Other Operating Activities | -18.68 | -6.24 | -19.5 | -50.63 | -42.05 |
Change in Accounts Receivable | -17.85 | - | - | - | - |
Change in Inventory | -13.86 | -14.35 | -3.98 | - | - |
Change in Accounts Payable | 2.12 | 0.1 | - | -0.01 | - |
Change in Unearned Revenue | -0.71 | -0.6 | -0.92 | -0.98 | 1.37 |
Change in Other Net Operating Assets | 13.45 | -52.22 | 50.6 | -47.53 | -18.3 |
Operating Cash Flow | -67.67 | -118.44 | -49.03 | -140.62 | -88.47 |
Capital Expenditures | -7.64 | -47.14 | -17.72 | -30.04 | -34.27 |
Sale of Property, Plant & Equipment | - | - | 0.11 | - | - |
Sale (Purchase) of Intangibles | - | - | -0.26 | - | -0.43 |
Investment in Securities | -188.8 | - | -15 | -74.66 | - |
Other Investing Activities | 0.45 | - | 4 | 4.01 | 0.97 |
Investing Cash Flow | -195.99 | -47.14 | -28.86 | -100.69 | -33.73 |
Long-Term Debt Repaid | -1.41 | -2.06 | -5.26 | -3.59 | -4.29 |
Total Debt Repaid | -1.41 | -2.06 | -5.26 | -3.59 | -4.29 |
Net Debt Issued (Repaid) | -1.41 | -2.06 | -5.26 | -3.59 | -4.29 |
Issuance of Common Stock | - | - | - | - | 395.25 |
Repurchase of Common Stock | - | - | - | -29.44 | - |
Other Financing Activities | 155.22 | -0.39 | -0.56 | -2.15 | -7.27 |
Financing Cash Flow | 153.81 | -2.44 | -5.82 | -35.18 | 383.68 |
Foreign Exchange Rate Adjustments | -0.26 | 0.97 | 1.82 | 19.27 | -6.61 |
Net Cash Flow | -110.1 | -167.05 | -81.88 | -257.21 | 254.86 |
Free Cash Flow | -75.3 | -165.58 | -66.74 | -170.65 | -122.75 |
Free Cash Flow Margin | -167.59% | - | - | - | - |
Free Cash Flow Per Share | -0.31 | -0.68 | -0.27 | -0.70 | -0.56 |
Cash Interest Paid | 0.38 | 0.06 | - | - | - |
Levered Free Cash Flow | -72.07 | -134.87 | -3.8 | -77.41 | 26.76 |
Unlevered Free Cash Flow | -66.6 | -134.83 | -3.44 | -76.81 | 27.19 |
Change in Working Capital | -16.83 | -67.07 | 45.71 | -48.52 | -16.93 |